Lyra Therapeutics trading halted, news pending
PremiumThe FlyLyra Therapeutics trading halted, news pending
4M ago
Target upgraded, CVS downgraded: Wall Street’s top analyst calls
Premium
The Fly
Target upgraded, CVS downgraded: Wall Street’s top analyst calls
5M ago
Target upgraded, CVS downgraded: Wall Street’s top analyst calls
Premium
The Fly
Target upgraded, CVS downgraded: Wall Street’s top analyst calls
5M ago
Lyra Therapeutics downgraded to Market Perform from Outperform at William Blair
PremiumThe FlyLyra Therapeutics downgraded to Market Perform from Outperform at William Blair
5M ago
Lyra announces Phase 3 ENLIGHTEN 1 trial did not meet primary endpoint
Premium
The Fly
Lyra announces Phase 3 ENLIGHTEN 1 trial did not meet primary endpoint
5M ago
Lyra Therapeutics Reports Topline Results from Phase 3 ENLIGHTEN 1 Trial for LYR-210 in Chronic Rhinosinusitis
Premium
Press Releases
Lyra Therapeutics Reports Topline Results from Phase 3 ENLIGHTEN 1 Trial for LYR-210 in Chronic Rhinosinusitis
5M ago
Lyra Therapeutics Announces Board and Committee Changes
PremiumCompany AnnouncementsLyra Therapeutics Announces Board and Committee Changes
5M ago
Lyra Therapeutics management to meet with Cantor Fitzgerald
Premium
The Fly
Lyra Therapeutics management to meet with Cantor Fitzgerald
5M ago
Lyra Therapeutics management to meet with Cantor Fitzgerald
Premium
The Fly
Lyra Therapeutics management to meet with Cantor Fitzgerald
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100